Go Pro

AirSculpt Technologies (NASDAQ:AIRS) Posts Earnings Results

AirSculpt Technologies logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • AirSculpt Technologies missed quarterly expectations: The company reported EPS of $0.01 versus the $0.02 consensus estimate, while revenue of $42.90 million came in below the $44.14 million forecast. It also posted a negative net margin of 7.39%.
  • Analysts remain cautious on the stock: AIRS has a consensus rating of “Reduce” and an average price target of $4.50, below its $5.01 opening price, despite one research firm upgrading the shares to “buy.”
  • Institutional ownership is substantial: Hedge funds and other institutional investors own 91.54% of AirSculpt Technologies, with several firms initiating or increasing positions during the fourth quarter.
  • Interested in AirSculpt Technologies? Here are five stocks we like better.

AirSculpt Technologies (NASDAQ:AIRS - Get Free Report) issued its quarterly earnings data on Monday. The company reported $0.01 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.02 by ($0.01), FiscalAI reports. AirSculpt Technologies had a negative net margin of 7.39% and a negative return on equity of 4.98%. The business had revenue of $42.90 million for the quarter, compared to analyst estimates of $44.14 million.

AirSculpt Technologies Price Performance

Shares of NASDAQ:AIRS opened at $5.01 on Monday. AirSculpt Technologies has a 1 year low of $1.51 and a 1 year high of $12.00. The company has a market capitalization of $353.46 million, a PE ratio of -29.47 and a beta of 2.33. The business has a fifty day moving average price of $4.74 and a two-hundred day moving average price of $3.56. The company has a debt-to-equity ratio of 0.39, a current ratio of 0.75 and a quick ratio of 0.75.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on AIRS. Wall Street Zen upgraded AirSculpt Technologies from a "hold" rating to a "buy" rating in a research note on Saturday, June 27th. Weiss Ratings raised AirSculpt Technologies from a "sell (e+)" rating to a "sell (d-)" rating in a research report on Wednesday, July 1st. Finally, Leerink Partners set a $4.50 price target on AirSculpt Technologies in a report on Thursday, May 14th. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Reduce" and an average price target of $4.50.

Get Our Latest Stock Report on AirSculpt Technologies

Hedge Funds Weigh In On AirSculpt Technologies

A number of hedge funds and other institutional investors have recently made changes to their positions in AIRS. Virtu Financial LLC purchased a new stake in AirSculpt Technologies in the fourth quarter worth $30,000. XTX Topco Ltd grew its stake in shares of AirSculpt Technologies by 265.2% during the 4th quarter. XTX Topco Ltd now owns 179,813 shares of the company's stock worth $356,000 after acquiring an additional 130,581 shares during the period. Tudor Investment Corp ET AL purchased a new stake in AirSculpt Technologies in the 4th quarter worth about $219,000. Saba Capital Management L.P. purchased a new stake in AirSculpt Technologies in the 4th quarter worth about $620,000. Finally, Millennium Management LLC purchased a new stake in AirSculpt Technologies in the 4th quarter worth about $33,000. 91.54% of the stock is owned by hedge funds and other institutional investors.

AirSculpt Technologies Company Profile

(Get Free Report)

AirSculpt Technologies, Inc NASDAQ: AIRS is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.

Read More

Earnings History for AirSculpt Technologies (NASDAQ:AIRS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in AirSculpt Technologies Right Now?

Before you consider AirSculpt Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AirSculpt Technologies wasn't on the list.

While AirSculpt Technologies currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines